• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于改善溃疡性结肠炎大鼠模型结肠靶向性的埃索美拉唑固体脂质纳米粒

Eluxadoline Loaded Solid Lipid Nanoparticles for Improved Colon Targeting in Rat Model of Ulcerative Colitis.

作者信息

Anwer Md Khalid, Ahmed Mohammed Muqtader, Aldawsari Mohammed F, Alshahrani Saad, Fatima Farhat, Ansari Mohd Nazam, Rehman Najeeb Ur, Al-Shdefat Ramadan I

机构信息

Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.

Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.

出版信息

Pharmaceuticals (Basel). 2020 Sep 19;13(9):255. doi: 10.3390/ph13090255.

DOI:10.3390/ph13090255
PMID:32961713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7559404/
Abstract

The aim of the current study was to evaluate the therapeutics potential of eluxadoline (ELX) loaded solid lipid nanoparticles (SLNs) in ulcerative colitis. ELX loaded SLNs were prepared using three different lipids according to the solvent emulsification technique. The optimization of prepared SLNs (F1-F3) were carried out based on size, PDI, zeta potential, percent drug entrapment (%EE), and loading (%DL). The lipid (stearic acid) based SLNs (F2) was optimized with particle size (266.0 ± 6.4 nm), PDI (0.217 ± 0.04), zeta potential (31.2 ± 5.19 mV), EE (65.0 ± 4.8%), and DL (4.60 ± 0.8%). The optimized SLNs (F2) was further evaluated by DSC, FTIR, SEM, in vitro release, and stability studies, which confirmed the successful encapsulation of ELX in SLNs. The efficacy of optimized SLNs (F2) in comparison to the pure ELX drug was assessed in acetic acid induced colitis rat models. It was observed that the delivery of ELX by SLNs alleviated the induced acetic acid colitis significantly. Thus, ELX loaded SLNs delivery to the colon has a significant potential to be developed for the treatment of ulcerative colitis.

摘要

本研究的目的是评估载有埃卢多啉(ELX)的固体脂质纳米粒(SLNs)在溃疡性结肠炎中的治疗潜力。根据溶剂乳化技术,使用三种不同的脂质制备了载有ELX的SLNs。基于粒径、多分散指数(PDI)、zeta电位、药物包封率(%EE)和载药量(%DL)对制备的SLNs(F1-F3)进行优化。基于硬脂酸的SLNs(F2)的粒径为(266.0±6.4nm),PDI为(0.217±0.04),zeta电位为(31.2±5.19mV),EE为(65.0±4.8%),DL为(4.60±0.8%),得到优化。通过差示扫描量热法(DSC)、傅里叶变换红外光谱法(FTIR)、扫描电子显微镜(SEM)、体外释放和稳定性研究对优化后的SLNs(F2)进行进一步评估,证实ELX成功包封在SLNs中。在乙酸诱导的结肠炎大鼠模型中评估了优化后的SLNs(F2)与纯ELX药物相比的疗效。观察到SLNs递送ELX可显著减轻诱导的乙酸结肠炎。因此,载有ELX的SLNs递送至结肠具有开发用于治疗溃疡性结肠炎的巨大潜力。

相似文献

1
Eluxadoline Loaded Solid Lipid Nanoparticles for Improved Colon Targeting in Rat Model of Ulcerative Colitis.用于改善溃疡性结肠炎大鼠模型结肠靶向性的埃索美拉唑固体脂质纳米粒
Pharmaceuticals (Basel). 2020 Sep 19;13(9):255. doi: 10.3390/ph13090255.
2
Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis.载有非索非那定的壳聚糖包被固体脂质纳米粒(SLNs):溃疡性结肠炎的一种潜在口服治疗方法。
Eur J Pharm Biopharm. 2024 Mar;196:114205. doi: 10.1016/j.ejpb.2024.114205. Epub 2024 Feb 3.
3
Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.布加替尼固体脂质纳米粒的制备及特性研究:对人肺癌 A549 细胞系的体外细胞毒性。
Chem Phys Lipids. 2020 Nov;233:105003. doi: 10.1016/j.chemphyslip.2020.105003. Epub 2020 Oct 20.
4
Chitosan-Coated Solid Lipid Nanoparticles as an Efficient Avenue for Boosted Biological Activities of : Antioxidant, Antibacterial, and Anticancer Potential.壳聚糖包覆的固体脂质纳米粒作为提高:抗氧化、抗菌和抗癌潜力的生物活性的有效途径。
Molecules. 2023 Apr 19;28(8):3569. doi: 10.3390/molecules28083569.
5
Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.多潘立酮固体脂质纳米粒的研制:体外与体内特性考察。
AAPS PharmSciTech. 2018 May;19(4):1712-1719. doi: 10.1208/s12249-018-0987-2. Epub 2018 Mar 12.
6
Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.脂质基质对用于口服给药的瑞格列奈载药固体脂质纳米粒的影响。
Ther Deliv. 2010 Jul;1(1):63-73. doi: 10.4155/tde.10.7.
7
Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats.盐酸托莫西汀固体脂质纳米粒冻干鼻用插入剂用于脑靶向治疗注意力缺陷多动障碍(ADHD):大鼠药代动力学研究
Pharmaceuticals (Basel). 2023 Feb 20;16(2):326. doi: 10.3390/ph16020326.
8
Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, characterization, cell line studies and efficacy in schizophrenia.盐酸鲁拉西酮固体脂质纳米粒的口服给药制备:优化、表征、细胞系研究及在精神分裂症中的疗效。
Drug Dev Ind Pharm. 2019 Aug;45(8):1242-1257. doi: 10.1080/03639045.2019.1593434. Epub 2019 Jun 6.
9
Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.载有伊拉地平的固体脂质纳米粒对大鼠药效学作用的研究
Drug Res (Stuttg). 2017 Mar;67(3):163-169. doi: 10.1055/s-0042-119947. Epub 2016 Dec 19.
10
Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.载柚皮素固体脂质纳米粒:制备、控释、细胞摄取及肺部药代动力学
Drug Des Devel Ther. 2016 Mar 1;10:911-25. doi: 10.2147/DDDT.S97738. eCollection 2016.

引用本文的文献

1
Anti-Inflammatory Effect of Goat Milk Against Acetic Acid-Induced Ulcerative Colitis in Rat Model.山羊奶对大鼠乙酸诱导型溃疡性结肠炎的抗炎作用
Food Sci Nutr. 2025 Aug 8;13(8):e70641. doi: 10.1002/fsn3.70641. eCollection 2025 Aug.
2
Oral Lipid Nanoparticles for Improving the Efficiency of Drug Delivery Systems in Ulcerative Colitis: Recent Advances and Future Prospects.用于提高溃疡性结肠炎药物递送系统效率的口服脂质纳米粒:最新进展与未来前景
Pharmaceutics. 2025 Apr 23;17(5):547. doi: 10.3390/pharmaceutics17050547.
3
Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells.

本文引用的文献

1
Lipid-based carriers for the delivery of local anesthetics.脂质体载体用于局部麻醉剂的递送。
Expert Opin Drug Deliv. 2019 Jul;16(7):701-714. doi: 10.1080/17425247.2019.1629415. Epub 2019 Jun 20.
2
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.患者及疾病特征对eluxadoline治疗腹泻型肠易激综合征疗效和安全性的影响:一项III期试验的亚组分析
Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841290. doi: 10.1177/1756284819841290. eCollection 2019.
3
Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats.
用于治疗乳腺癌的吉非替尼载药固体脂质纳米粒的研发:物理化学评估、稳定性及对乳腺癌(MCF-7)细胞的抗癌活性
Pharmaceuticals (Basel). 2023 Nov 2;16(11):1549. doi: 10.3390/ph16111549.
4
Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box-Behnken Design, and Anti-Diarrheal Activity.载有埃洛昔丁的聚丙烯酸树脂纳米颗粒用于腹泻型肠易激综合征:制剂、采用Box-Behnken设计的优化及止泻活性
Pharmaceutics. 2023 May 10;15(5):1460. doi: 10.3390/pharmaceutics15051460.
5
The diarrheal mechanism of mice with a high-fat diet in a fatigued state is associated with intestinal mucosa microbiota.处于疲劳状态的高脂饮食小鼠的腹泻机制与肠道黏膜微生物群有关。
3 Biotech. 2023 Mar;13(3):77. doi: 10.1007/s13205-023-03491-5. Epub 2023 Feb 6.
6
Design and Evaluation of Solid Lipid Nanoparticles Loaded Topical Gels: Repurpose of Fluoxetine in Diabetic Wound Healing.载有局部用凝胶的固体脂质纳米粒的设计与评价:氟西汀在糖尿病伤口愈合中的新用途
Gels. 2022 Dec 27;9(1):21. doi: 10.3390/gels9010021.
7
Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach.通过脂质聚合物杂化纳米颗粒方法增强苹果酸舒尼替尼在乳腺癌中的抗癌活性。
Polymers (Basel). 2022 Jun 16;14(12):2459. doi: 10.3390/polym14122459.
8
The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis.马来酸曲美布汀载药纳米脂质载体的改良对缓解急性结肠炎严重程度的保护作用。
Drug Deliv. 2022 Dec;29(1):906-924. doi: 10.1080/10717544.2022.2050847.
9
Improving the Solubilization and Bioavailability of Arbidol Hydrochloride by the Preparation of Binary and Ternary β-Cyclodextrin Complexes with Poloxamer 188.通过制备盐酸阿比多尔与泊洛沙姆188的二元和三元β-环糊精复合物提高其溶解度和生物利用度
Pharmaceuticals (Basel). 2021 Apr 26;14(5):411. doi: 10.3390/ph14050411.
10
Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing.表皮生长因子(Epicertin)的喷雾干燥制剂,一种诱导黏膜愈合的重组霍乱毒素B亚基变体
Pharmaceutics. 2021 Apr 18;13(4):576. doi: 10.3390/pharmaceutics13040576.
载阿普司特聚乳酸-羟基乙酸共聚物纳米粒的制备及其在大鼠体内的药代动力学研究。
Int J Nanomedicine. 2019 Mar 1;14:1587-1595. doi: 10.2147/IJN.S195048. eCollection 2019.
4
Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome.用于度洛西汀持续释放以治疗肠易激综合征的尤特奇包衣聚乳酸-羟基乙酸共聚物纳米粒的制备、评价及生物利用度研究
Front Pharmacol. 2017 Nov 20;8:844. doi: 10.3389/fphar.2017.00844. eCollection 2017.
5
High throughput μ-SPE based elution coupled with UPLC-MS/MS for determination of eluxadoline in plasma sample: Application in pharmacokinetic characterization of PLGA nanoparticle formulations in rats.基于高通量 μ-SPE 的洗脱结合 UPLC-MS/MS 用于测定血浆样品中的埃卢索多林:在大鼠中 PLGA 纳米粒制剂的药代动力学特征研究中的应用。
J Pharm Biomed Anal. 2018 Feb 5;149:172-178. doi: 10.1016/j.jpba.2017.10.024. Epub 2017 Oct 28.
6
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.用于靶向脑部疾病的固体脂质纳米粒和纳米结构脂质载体的设计进展。
J Control Release. 2017 Oct 28;264:306-332. doi: 10.1016/j.jconrel.2017.08.033. Epub 2017 Aug 26.
7
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.树状高分子作为用于癌症治疗中核酸和药物传递的纳米载体。
Molecules. 2017 Aug 23;22(9):1401. doi: 10.3390/molecules22091401.
8
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective.
Rev Esp Enferm Dig. 2017 Nov;109(11):788-794. doi: 10.17235/reed.2017.5078/2017.
9
Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics.肝功能损害对埃卢多啉药代动力学的影响。
J Clin Pharmacol. 2017 Nov;57(11):1454-1459. doi: 10.1002/jcph.964. Epub 2017 Jul 18.
10
Potential of Liposomes for Enhancement of Oral Drug Absorption.脂质体增强口服药物吸收的潜力。
Curr Drug Deliv. 2017;14(2):289-303. doi: 10.2174/1567201813666160115125756.